Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability

Cell

Volumn 109, Issue 6, 2002, Pages 707-718

  McGill, Gaël G ^a   Horstmann, Martin ^a   Widlund, Hans R ^a   Du, Jinyan ^a   Motyckova, Gabriela ^a   Nishimura, Emi K ^a   Lin, Yi Ling ^a   Ramaswamy, Sridhar ^a,b   Avery, William ^c   Ding, Han Fei ^a   Jordan, Siobhán A ^d   Jackson, Ian J ^d   Korsmeyer, Stanley J ^c   Golub, Todd R ^a,b   Fisher, David E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MITF; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL LINEAGE; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE DELETION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC LINKAGE; GERM LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOMA CELL; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; UNINDEXED SEQUENCE;

ANIMALIA;

EID: 18444418797     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00762-6     Document Type: Article

References (57)

1. Genasense (Genta Inc)
2. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes
3. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility
4. Nerve growth factor induces the expression of certain cytokine genes and Bcl2 in mast cells. Potential role in survival promotion
5. The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes
6. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of Bcl2
7. Bcl2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi
8. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors
9. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
10. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo
11. Microphthalmia transcription factor
12. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin
13. Mitf from neural crest to melanoma: Signal transduction and transcription in the melanocyte lineage
14. BCL-2 family members and the mitochondria in apoptosis
15. Bcl2 expression in malignant melanoma and its prognostic significance
16. Human melanocytes cultured from nevi and melanomas
17. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family
18. MAP kinase links the transcription factor Microphthalmia to Kit signalling in melanocytes
19. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1
20. Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice
21. Chemosensitisation of malignant melanoma by BCL2 antisense therapy
22. CREB and its associated proteins act as survival factors for human melanoma cells
23. Bcl2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine
24. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis
25. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors
26. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics
27. Enforced expression of Bcl2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice
28. A mouse model for vitiligo
29. Expression monitoring by hybridization to high-density oligonucleotide arrays
30. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo
31. Human mast cell apoptosis is regulated through Bcl2 and Bcl-XL
32. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: Comparison with four other melanoma markers
33. Insight into the microphthalmia gene
34. Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family
35. Targeted disruption of Bcl2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia
36. Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently
37. Dominant role of the niche in melanocyte stem-cell fate determination
38. Sensorineural deafness and pigmentation genes: Melanocytes and the Mitf transcriptional network
39. Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia
40. Insulin-like growth factor-I induces Bcl2 promoter through the transcription factor cAMP-response element-binding protein
41. Akt/protein kinase B up-regulates Bcl2 expression through cAMP-response element-binding protein
42. Bcl2 protein expression in melanocytic neoplasms of the skin
43. Bcl2 family proteins
44. Hereditary anemias of the mouse: A review for geneticists
45. Expression of Bcl2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
46. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences
47. SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast
48. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
49. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene
50. Bcl2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
51. Bcl2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
52. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TFE3
53. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice
54. SCF locus defines new multipotent growth factor
55. Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi
56. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9
57. Accelerated disappearance of melanocytes in Bcl2-deficient mice